You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Myeloid Leukemia

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022

Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

Terminated
Has Results
  • Chronic Phase Chronic Myeloid Leukemia
  • Ponatinib 30 mg QD
  • +2 more
  • Bruxelles, Belgium
    Cliniques Universitaire Saint-Luc (Site 058)
Oct 28, 2021

Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia

Not yet recruiting
  • Tyrosine Kinase Inhibitor
  • +2 more
    • Taipei, Taiwan
      National Taiwan University Hospital
    Feb 17, 2022

    Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Nilotinib
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Mar 15, 2022

    Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

    Recruiting
    • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Jena, Germany
      Universitätsklinikum Jena
    Jan 17, 2023

    TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy

    Recruiting
    • Chronic Myeloid Leukemia
    • Pisa, Italy
    • +1 more
    Jan 4, 2022

    MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Subcutaneous azacitidine
    • Oral decitabine/cedazuridine
    • Newcastle, New South Wales, Australia
      Calvary Mater Newcastle
    May 29, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)

    Recruiting
    • Myeloid Leukemia, Acute
    • +3 more
    • Saint Petersburg, Russian Federation
      RM Gorbacheva Research Institute
    Apr 4, 2022

    Chronic Myeloid Leukaemia Recurrent, Chronic Myeloid Leukemia, in Relapse Trial in Huixquilucan (Myeloid mutations measurement)

    Recruiting
    • Chronic Myeloid Leukaemia Recurrent
    • Chronic Myeloid Leukemia, in Relapse
    • Myeloid mutations measurement
    • Huixquilucan, Estado De México, Mexico
      Grupo Cooperativo de Hemopatías Malignas
    Oct 4, 2021

    Chronic Myeloid Leukemia Trial in Worldwide (Bosutinib, Ropeginterferon)

    Recruiting
    • Chronic Myeloid Leukemia
    • Aalborg, Denmark
    • +17 more
    Apr 4, 2022

    Outcomes in Chronic Myeloid Leukaemia

    Completed
    • Chronic Myeloid Leukaemia
      • York, United Kingdom
        Haematological Malignancy Research Network
      Jun 7, 2023

      Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

      Active, not recruiting
      • Chronic Myelogenous Leukemia
      • Amman, Jordan
      • +4 more
      Jan 17, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +10 more
      • Jacksonville, Florida
      • +5 more
      Aug 14, 2023

      Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

      Recruiting
      • Myelofibrosis
      • +2 more
      • Charlottesville, Virginia
        Danyelle Coley
      Jan 18, 2023

      Leukemia,Myeloid, Chronic Trial in France (Blood and bone marrow sample)

      Not yet recruiting
      • Leukemia,Myeloid, Chronic
      • Blood and bone marrow sample
      • Annecy, France
      • +15 more
      Nov 10, 2023

      Chronic Myeloid Leukemia Trial in France (biological samples)

      Completed
      • Chronic Myeloid Leukemia
      • biological samples
      • Belfort, France
      • +3 more
      May 31, 2022

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

      Not yet recruiting
      • Myelodysplastic Syndrome
      • +4 more
      • UAE Inhibitor TAK-243
      • (no location specified)
      Oct 20, 2022

      Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Beijing, China
        Peking University People's Hospital(北京大学人民医院)
      Jan 3, 2022

      Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions Trial in Ann Arbor (Patient Reported Outcome

      Terminated
      • Chronic Myeloid Leukemia
      • +2 more
      • Patient Reported Outcome Measure (PROM)
      • +2 more
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Nov 21, 2022

      Intravenous Busulfan And Fludarabine Myeloablative Conditioning

      Completed
      • Acute Myeloid Leukemia
      • +3 more
        • (no location specified)
        Mar 16, 2022

        Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic

        Recruiting
        • Folate
        • +2 more
          • Nantong, China
            Affliated Hospital of Nantong University
          Dec 13, 2021